Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.


This Says Our Favorite Biotech Is Off to the Races

Shares of a promising biotech we recommended back in February 2013 – jumped as much as 27% to a three-month high of $14.20 yesterday after the company said a new cancer drug met its main goal in a midstage clinical trial.

Its shares backtracked a bit as the day progressed but still closed 17.6% higher for the session. These shares have advanced 361% since we first told you about them. The stock has generated a peak gain of 456%, making it one of the 31 recommendations we’ve made to you that have doubled or better since we launched Private Briefing in August 2011. (More on that later…)

  • Featured Story

    DJIA Today Moving on GE, MS, MCD, and YUM News

    DJIA Today

    DJIA today, July 21, 2014: The Dow Jones Industrial Average bounced back on Friday, up more than 100 points following Thursday's 161 point drop. Geopolitical tensions remain high following the attack on a Malaysian jet airliner over Ukrainian skies Thursday morning, and Israel's tactical launch inside Gaza.

    The rebound on Friday suggests that investors are paying more attention to second-quarter earnings than events in Ukraine and Gaza.

    Here’s the news moving the DJIA today:
  • DJIA